Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO)
CUSIP: 869367102
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 84,733,230
- Total 13F shares
- 41,241,047
- Share change
- -3,119,270
- Total reported value
- $766,657,023
- Put/Call ratio
- 88%
- Price per share
- $18.59
- Number of holders
- 121
- Value change
- -$71,886,996
- Number of buys
- 62
- Number of sells
- 66
Quarterly Holders Quick Answers
What is CUSIP 869367102?
CUSIP 869367102 identifies STRO - Sutro Biopharma, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 869367102:
Top shareholders of STRO - Sutro Biopharma, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
3.7%
|
3,101,973
|
$70,601,000 | — | 31 Mar 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3.1%
|
2,646,804
|
$60,241,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
3%
|
2,514,164
|
$57,222,000 | — | 31 Mar 2021 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2.8%
|
2,370,975
|
$53,963,000 | — | 31 Mar 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.5%
|
2,118,212
|
$48,211,000 | — | 31 Mar 2021 | |
| First Light Asset Management, LLC |
13F
|
Company |
2.4%
|
2,058,447
|
$46,850,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.4%
|
2,039,989
|
$46,431,000 | — | 31 Mar 2021 | |
| SV Health Investors, LLC |
13F
|
Company |
2.2%
|
1,824,542
|
$41,527,000 | — | 31 Mar 2021 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
2%
|
1,695,654
|
$38,593,000 | — | 31 Mar 2021 | |
| Samsara BioCapital, LLC |
13F
|
Company |
2%
|
1,675,579
|
$38,136,000 | — | 31 Mar 2021 | |
| Holocene Advisors, LP |
13F
|
Company |
1.7%
|
1,423,205
|
$32,392,000 | — | 31 Mar 2021 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.6%
|
1,354,993
|
$30,840,000 | — | 31 Mar 2021 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,284,976
|
$29,246,000 | — | 31 Mar 2021 | |
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
1.2%
|
1,001,421
|
$22,792,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
976,620
|
$22,228,000 | — | 31 Mar 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.1%
|
958,200
|
$21,809,000 | — | 31 Mar 2021 | |
| BVF INC/IL |
13F
|
Company |
0.98%
|
826,825
|
$18,819,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.91%
|
773,106
|
$17,596,000 | — | 31 Mar 2021 | |
| FIL Ltd |
13F
|
Company |
0.91%
|
771,790
|
$17,565,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
0.87%
|
737,300
|
$16,781,000 | — | 31 Mar 2021 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.68%
|
573,823
|
$13,060,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.67%
|
566,649
|
$12,896,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.66%
|
556,799
|
$12,673,000 | — | 31 Mar 2021 | |
| Verition Fund Management LLC |
13F
|
Company |
0.56%
|
471,332
|
$10,728,000 | — | 31 Mar 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.53%
|
450,300
|
$10,249,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.45%
|
385,228
|
$8,768,000 | — | 31 Mar 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.43%
|
362,177
|
$8,229,000 | — | 31 Mar 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.41%
|
350,000
|
$7,966,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.41%
|
344,321
|
$7,837,000 | — | 31 Mar 2021 | |
| Opaleye Management Inc. |
13F
|
Company |
0.4%
|
341,950
|
$7,783,000 | — | 31 Mar 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.43%
|
368,110
|
$7,677,000 | — | 31 Mar 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.39%
|
328,774
|
$7,483,000 | — | 31 Mar 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.38%
|
320,444
|
$7,294,000 | — | 31 Mar 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.35%
|
294,825
|
$6,710,000 | — | 31 Mar 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.35%
|
293,033
|
$6,670,000 | — | 31 Mar 2021 | |
| Lombard Odier Asset Management (Switzerland) SA |
13F
|
Company |
0.34%
|
290,418
|
$6,610,000 | — | 31 Mar 2021 | |
| Lombard Odier SCmA Compagnie |
13F
|
Individual |
0.34%
|
290,418
|
$6,610,000 | — | 31 Mar 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.31%
|
260,123
|
$5,919,000 | — | 31 Mar 2021 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.28%
|
237,393
|
$5,404,000 | — | 31 Mar 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.27%
|
226,719
|
$5,160,000 | — | 31 Mar 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.26%
|
218,800
|
$4,980,000 | — | 31 Mar 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.25%
|
215,974
|
$4,916,000 | — | 31 Mar 2021 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.25%
|
212,209
|
$4,830,000 | — | 31 Mar 2021 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.24%
|
202,696
|
$4,613,000 | — | 31 Mar 2021 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.22%
|
184,501
|
$4,199,000 | — | 31 Mar 2021 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.21%
|
177,343
|
$4,038,000 | — | 31 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.2%
|
169,594
|
$3,860,000 | — | 31 Mar 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.19%
|
162,472
|
$3,704,000 | — | 31 Mar 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.17%
|
146,274
|
$3,330,000 | — | 31 Mar 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.17%
|
143,735
|
$3,271,000 | — | 31 Mar 2021 |
Institutional Holders of Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) as of Q2 2021
As of 30 Jun 2021,
Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,241,047 shares.
The largest 10 holders included
BlackRock Inc., FRANKLIN RESOURCES INC, EVENTIDE ASSET MANAGEMENT, LLC, STATE STREET CORP, First Light Asset Management, LLC, VANGUARD GROUP INC, SV Health Investors, LLC, BAILLIE GIFFORD & CO, SUVRETTA CAPITAL MANAGEMENT, LLC, and Samsara BioCapital, LLC.
This page lists
121
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
136
Q2 2021 holders
121
Holder diff
-15
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.